Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07725900) titled 'Clinical Efficacy and Safety of MB Luxury? Product Containing Epigallocathecin Gallate (EGCG) on Erythema, Melanin, and Skin Hydration' on July 21.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Naniek Widyaningrum
Condition:
Hyperpigmentation
Dry Skin
Erythema
Intervention:
Other: MB Luxury Skincare containing Epigallocatechin Gallate (EGCG)
Recruitment Status: Not recruiting
Phase: Phase 2/Phase 3
Date of First Enrollment: December 1, 2025
Target Sample Size: 300
Coun...